Philip McTernan, Associate Professor, Warwick Medical School
Published January 2014
And don't forget to tweet your results so can claim sweet-tasting victory over your friends!
Dr Philip McTernan is part of a team, at the Warwick Medical School, which works on several of these factors to examine how they impact on the progression of the disease and its complications, such as hypertension and the risk of heart disease. The team performs both clinical and laboratory patient-based studies, assessing the effects of risk factors on fat as well as the role of drug treatment on reducing pathogenic factors produced by fat.
The studies aim to provide a deeper understanding of how present drug and or diet intervention impact on our health with particular emphasis of how human fat cells may contribute to this risk. The team looks into way to disease risk imposed by obesity and type 2 diabetes. The multidisciplinary team works across several cross-clinical specialists and academic departments (Biology, Chemistry, Maths and Systems Biology). Key research includes studies into role of inflammation in the progression of obesity and Type 2 Diabetes Mellitus; how our gut flora may impact on our health and the influence of both medication and inflammatory factors impact on human fat cell metabolism.
Main Image: Taste Tester by Amanda Tipton via Flickr